India’s TB Elimination Efforts: Progress, Surveillance Gaps and the Road Ahead

Context
The WHO’s 2026 Global Tuberculosis (TB) Report has placed India’s estimated TB incidence figures under review, pending the validation of findings from a 50-district sentinel surveillance survey conducted in 2025. This has brought attention to the need for reliable disease surveillance, transparent reporting and accurate measurement of India’s progress towards TB elimination.
About the WHO Global TB Report
The World Health Organization (WHO) Global TB Report is an annual flagship publication that assesses the global tuberculosis burden and evaluates countries’ progress in prevention, diagnosis and treatment.
- It tracks progress against the WHO’s End TB Strategy, which aims to significantly reduce TB incidence and mortality.
- It provides estimates of TB incidence, mortality, treatment coverage and drug-resistant TB across countries.
- It helps governments identify gaps between reported cases and the actual disease burden.
Why is estimated TB incidence important?
- Estimated incidence refers to the total number of new and recurrent TB cases occurring in a population, including cases that remain undiagnosed.
- Notified cases represent patients diagnosed and officially reported to health authorities.
- The difference between these figures indicates the extent of undetected TB and weaknesses in diagnosis and reporting.
Why Are India’s TB Incidence Estimates Under Review?
India traditionally relied on large-scale national prevalence surveys to estimate its TB burden. However, conducting such surveys across the entire population is expensive and resource-intensive.
- Earlier Surveys: India conducted nationwide TB prevalence surveys during 1955–58 and 2020–21.
- New Surveillance Approach: In 2025, India undertook a population-based sentinel surveillance survey covering 50 representative districts.
- Technical Validation: WHO statisticians are assessing the new findings against the 2020–21 baseline to ensure consistency and statistical reliability.
- Reporting Implications: Until this exercise is completed, India’s estimated incidence figures have been withheld from the 2026 report.
This transition reflects an effort to develop a more regular and sustainable mechanism for measuring the country’s TB burden.
Key Findings of the WHO Global TB Report 2026
1. Global Tuberculosis Burden
- Approximately 10.6 million people developed TB globally in 2025.
- Around 1.13 million people died from the disease, highlighting its continuing public health significance.
2. India’s Significant Share of Global TB Cases
- India continues to contribute nearly one-fourth of the global TB burden.
- The country notified approximately 25.3 lakh TB cases in 2025, compared with 26.18 lakh in 2024.
- The decline in notified cases is encouraging, although it does not independently establish a corresponding reduction in actual incidence.
3. Improvement in TB Mortality
- India recorded approximately 2.63 lakh TB deaths in 2025, compared with more than 3 lakh in 2024.
- TB mortality has declined by 38% since 2015, exceeding the global reduction of 35%.
- This achievement indicates progress in early diagnosis, treatment access and patient support.
4. Progress Towards WHO End TB Targets
- India has surpassed the WHO’s interim 2020 target of reducing TB mortality by 35% from the 2015 baseline.
- However, this milestone was achieved five years behind schedule.
- The country remains significantly short of the 2025 target of a 75% reduction in TB deaths.
5. Domestic Financing of TB Elimination
- Nearly 96% of India’s national TB programme expenditure is financed through domestic budgetary resources.
- This reflects India’s commitment to reducing dependence on external assistance and sustaining long-term public health interventions.
Major Government Initiatives for TB Elimination
1. National Tuberculosis Elimination Programme (NTEP)
- Reoriented India’s TB response from disease control towards elimination.
- Mandates notification of TB cases, including those diagnosed in the private healthcare sector.
- Uses the Ni-kshay digital platform for patient registration, treatment monitoring and programme tracking.
2. Nutritional Support through Ni-kshay Poshan Yojana
- Provides financial assistance through Direct Benefit Transfer (DBT) to support the nutritional requirements of TB patients.
- Recognises malnutrition as an important risk factor for TB vulnerability and poor treatment outcomes.
3. Community Participation through Ni-kshay Mitra
- Encourages individuals, organisations and institutions to adopt TB patients and provide nutritional and social support.
- Operates under the broader Pradhan Mantri TB Mukt Bharat Abhiyaan.
- Promotes community participation in reducing treatment-related vulnerabilities.
4. Expansion of Advanced Diagnostic Technologies
- Expands rapid molecular diagnostic facilities such as CBNAAT and Truenat for early detection of TB and drug resistance.
- Deploys portable, AI-enabled chest X-ray systems to improve screening, particularly in underserved regions.
- Supports earlier diagnosis and timely initiation of appropriate treatment.
5. Improved Treatment for Drug-Resistant TB
- Introduces shorter, safer and injection-free treatment regimens, including BPaL and BPaLM, for eligible patients with drug-resistant TB.
- These regimens aim to reduce treatment duration, improve adherence and increase treatment completion rates.
Major Challenges in India’s TB Elimination Efforts
1. Gaps in Data Transparency and Surveillance
- Delays in validating incidence estimates and publishing updated national TB data affect evidence-based policymaking.
- The absence of timely annual reporting limits the availability of state-wise and district-level information.
Example: Policymakers may lack updated information on regional notification rates, treatment outcomes and drug-resistance patterns, making it difficult to identify poorly performing districts.
2. Undiagnosed and Missing TB Cases
- A significant challenge is identifying patients who remain outside the formal healthcare system.
- Subclinical and asymptomatic infections, particularly in rural areas and urban informal settlements, can delay diagnosis.
- Dependence on informal healthcare providers and self-medication further increases diagnostic delays.
Example: Patients may initially rely on over-the-counter medicines or informal practitioners instead of accessing molecular diagnostic facilities.
3. Fragmentation of Private Healthcare Delivery
- Many patients initially approach private clinics and hospitals for TB diagnosis and treatment.
- Inconsistent diagnostic standards, inadequate drug-susceptibility testing and weak treatment monitoring can compromise care.
- High out-of-pocket expenditure can push economically vulnerable patients towards incomplete treatment.
Example: A patient may discontinue treatment because of the financial burden of private consultations, diagnostics and nutritional requirements.
4. Growing Concern over Multidrug-Resistant TB
- Drug-resistant TB makes treatment more complicated, expensive and prolonged.
- Inappropriate prescriptions and incomplete treatment courses can contribute to the emergence and transmission of drug-resistant strains.
- Limited access to specialised diagnostics and treatment facilities further aggravates the problem.
5. Social Stigma and Economic Vulnerability
- Fear of discrimination discourages individuals from seeking timely diagnosis and treatment.
- Women, migrant workers and daily-wage earners may conceal their illness due to concerns about social exclusion and loss of employment.
- Poor nutrition, overcrowded housing and inadequate sanitation increase vulnerability to TB.
6. Socioeconomic Determinants of Tuberculosis
- Poverty, undernutrition, overcrowding, indoor air pollution and poor living conditions contribute to TB transmission and disease progression.
- Medical interventions alone cannot eliminate TB without addressing these underlying determinants.
Way Forward
1. Strengthen Surveillance and Data Transparency
- Complete the validation of the 50-district sentinel survey in coordination with the WHO.
- Ensure timely publication of the annual India TB Report.
- Make district-level information on incidence, mortality, drug resistance and treatment outcomes publicly accessible.
2. Expand Decentralised Screening and Diagnosis
- Scale up AI-enabled portable chest X-rays and rapid molecular diagnostic facilities at primary healthcare institutions, including Ayushman Arogya Mandirs.
- Strengthen sample transportation networks to connect remote communities with diagnostic laboratories.
- Prioritise active case finding among high-risk populations.
3. Improve Private-Sector Integration
- Strengthen collaboration with private hospitals, clinics, pharmacies and diagnostic centres through Patient Provider Support Agencies (PPSAs).
- Ensure access to free, quality-assured medicines and diagnostic services.
- Improve mandatory notification, treatment adherence monitoring and patient follow-up.
4. Strengthen Preventive Healthcare
- Expand household contact tracing and screening of people exposed to infectious TB patients.
- Increase access to TB Preventive Treatment (TPT) among eligible high-risk individuals.
- Conduct systematic death audits to identify avoidable delays and weaknesses in treatment delivery.
5. Address Nutritional and Socioeconomic Vulnerabilities
- Strengthen nutritional assistance through Ni-kshay Poshan Yojana.
- Integrate TB interventions with poverty alleviation, food security and social protection programmes.
- Provide workplace protection and social support to reduce treatment discontinuation.
6. Promote Research and Innovation
- Invest in new vaccines, diagnostic technologies and shorter treatment regimens.
- Strengthen research into drug-resistant TB and patient-friendly treatment approaches.
- Encourage collaboration among research institutions, pharmaceutical companies and public health agencies.
Conclusion
India’s 38% reduction in TB mortality since 2015 demonstrates substantial progress in expanding diagnosis, treatment and nutritional support. However, the withholding of estimated incidence figures in the WHO’s 2026 report highlights the importance of credible and timely surveillance systems. Achieving TB elimination requires moving beyond reported case numbers towards identifying every missing patient, strengthening public-private healthcare coordination and addressing the socioeconomic conditions that sustain transmission. A data-driven, patient-centric and community-supported approach is essential to achieving India’s TB elimination ambitions.
Source : PIB